[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS8360A - Mótlyf styrkthjöppunarhormóns melaníns - Google Patents

Mótlyf styrkthjöppunarhormóns melaníns

Info

Publication number
IS8360A
IS8360A IS8360A IS8360A IS8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A
Authority
IS
Iceland
Prior art keywords
antagonist
melanin concentration
concentration hormone
hormone
melanin
Prior art date
Application number
IS8360A
Other languages
English (en)
Inventor
Erig Hu Xiufeng
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of IS8360A publication Critical patent/IS8360A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/79Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS8360A 2003-10-01 2006-03-17 Mótlyf styrkthjöppunarhormóns melaníns IS8360A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50777303P 2003-10-01 2003-10-01
US53664004P 2004-01-15 2004-01-15
PCT/US2004/031631 WO2005033063A2 (en) 2003-10-01 2004-09-24 Melanin concentrating hormone antagonists

Publications (1)

Publication Number Publication Date
IS8360A true IS8360A (is) 2006-03-17

Family

ID=34426018

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8360A IS8360A (is) 2003-10-01 2006-03-17 Mótlyf styrkthjöppunarhormóns melaníns

Country Status (20)

Country Link
US (1) US7304065B2 (is)
EP (1) EP1667958A2 (is)
JP (1) JP2007508303A (is)
KR (1) KR20060060047A (is)
CN (1) CN101068773A (is)
AR (1) AR045958A1 (is)
AU (1) AU2004278352B2 (is)
BR (1) BRPI0415051A (is)
CA (1) CA2540826A1 (is)
CO (1) CO5690589A2 (is)
IL (1) IL174370A0 (is)
IS (1) IS8360A (is)
MA (1) MA28079A1 (is)
MX (1) MXPA06003654A (is)
NO (1) NO20061953L (is)
PE (1) PE20050475A1 (is)
RU (1) RU2006110272A (is)
SG (1) SG146692A1 (is)
TW (1) TW200526554A (is)
WO (1) WO2005033063A2 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008001160A1 (en) * 2006-06-23 2008-01-03 The Procter & Gamble Company Melanin concentrating hormone antagonists
US7700599B2 (en) * 2006-06-28 2010-04-20 Glaxo Group Limited Gpr38 Receptor Agonists
WO2008044632A1 (fr) * 2006-10-06 2008-04-17 Taisho Pharmaceutical Co., Ltd. Dérivé de la 1-naphthyl alkylpipéridine
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
EP2025674A1 (de) * 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2009153720A1 (en) * 2008-06-18 2009-12-23 Pfizer Limited Nicotinamide derivatives
AR075401A1 (es) 2009-02-13 2011-03-30 Sanofi Aventis Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento
AR075402A1 (es) * 2009-02-13 2011-03-30 Sanofi Aventis Derivados heterociclicos oxigenados y/o nitrogenados de tetrahidronaftaleno, medicamentos que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad,entre otros.
WO2011083804A1 (ja) * 2010-01-06 2011-07-14 武田薬品工業株式会社 インドール誘導体

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206428A (en) * 1989-11-16 1993-04-27 Tanabe Seiyaku Co., Ltd. Tetrahydronaphthalene derivatives and preparation thereof
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
WO1994018204A1 (en) * 1993-02-12 1994-08-18 Merck & Co., Inc. Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics
WO1994027597A1 (en) 1993-05-21 1994-12-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acid angiotensin ii receptor antagonists
US5756496A (en) 1994-05-28 1998-05-26 Smithkline Beecham P.L.C. Amide derivatives having 5HT1D-antagonist activity
DE4438029A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K N.N-disubstituierte Benzocycloalkylamine, ihre Salze mit verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel
US6008219A (en) 1995-03-27 1999-12-28 Smithkline Beech P.L.C. Bicyclic amine derivatives and their use as anti-psychotic agents
DE19614718A1 (de) * 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
HU225960B1 (en) 1997-02-27 2008-01-28 Takeda Pharmaceutical Amine compounds, their production and use
WO2000009480A1 (fr) * 1998-08-11 2000-02-24 Daiichi Pharmaceutical Co., Ltd. Nouveaux derives sulfonyle
WO2001021577A2 (en) * 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
AU2001252596A1 (en) 2000-04-28 2001-11-12 Takeda Chemical Industries Ltd. Melanin concentrating hormone antagonists
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
CA2431953A1 (en) 2000-12-22 2002-07-04 Schering Corporation Piperidine mch antagonists and their use in the treatment of obesity
US6900329B2 (en) 2001-03-21 2005-05-31 Schering Corporation MCH antagonists and their use in the treatment of obesity
US7544690B2 (en) 2001-10-01 2009-06-09 Taisho Pharmaceutical Co., Ltd. MCH receptor antagonists
AU2002337956B2 (en) 2001-10-25 2006-02-23 Schering Corporation MCH Antagonists for the treatment of obesity
ES2333415T3 (es) 2001-11-26 2010-02-22 Schering Corporation Antagonistas de la mch basados en piperidina para el tratamiento de la obesidad y de trastornos del snc.
JP2005518365A (ja) 2001-11-27 2005-06-23 メルク エンド カムパニー インコーポレーテッド 4−アミノキノリン化合物
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
KR20050044664A (ko) 2001-12-04 2005-05-12 쉐링 코포레이션 비만 치료용 mch 길항제로서의n-아릴-n'-아릴사이클로알킬-우레아 유도체
DE10238865A1 (de) 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
BR0315566A (pt) * 2002-10-21 2005-08-23 Janssen Pharmaceutica Nv Tetralinas e indanos substituìdos
JP2006522825A (ja) * 2003-04-10 2006-10-05 アムジェン インコーポレイテッド ブラジキニンレセプター親和性を有する二環式化合物およびその薬学的組成物

Also Published As

Publication number Publication date
JP2007508303A (ja) 2007-04-05
IL174370A0 (en) 2006-08-01
RU2006110272A (ru) 2007-11-10
MXPA06003654A (es) 2006-06-05
BRPI0415051A (pt) 2006-11-28
US20050075324A1 (en) 2005-04-07
NO20061953L (no) 2006-06-13
KR20060060047A (ko) 2006-06-02
WO2005033063A2 (en) 2005-04-14
TW200526554A (en) 2005-08-16
CA2540826A1 (en) 2005-04-14
CN101068773A (zh) 2007-11-07
MA28079A1 (fr) 2006-08-01
AU2004278352B2 (en) 2008-10-30
EP1667958A2 (en) 2006-06-14
WO2005033063A3 (en) 2007-03-22
SG146692A1 (en) 2008-10-30
AR045958A1 (es) 2005-11-16
AU2004278352A1 (en) 2005-04-14
PE20050475A1 (es) 2005-10-05
US7304065B2 (en) 2007-12-04
CO5690589A2 (es) 2006-10-31

Similar Documents

Publication Publication Date Title
DE602004017700D1 (de) Transmukosen verabreichung
NO20034702D0 (no) Elektrode
ATE354631T1 (de) Nuancierungsmittel
DE60315135D1 (de) Therapiesonde
ATE394659T1 (de) Probenhomogenisator
DK1667992T3 (da) Quinazolinderivater
IS8360A (is) Mótlyf styrkthjöppunarhormóns melaníns
NO20035142D0 (no) N¶rhetsdetektor
ATE333271T1 (de) Uv-stabiles transdermales pflaster
NO20055143D0 (no) Doseringsformer innbefattende AG013736
DK1597171T3 (da) Terapeutisk mikroskum
NO20034599L (no) Brokonstruksjon
DE602004014239D1 (de) Betoniereinrichtung
ATA2792002A (de) Temperaturfühler
NO20034600D0 (no) Brokonstruksjon
ATE439379T1 (de) Chimärer antagonist anth1
NO20041286L (no) Gulvavlop
ATA2722003A (de) Schalung
NO20032032D0 (no) V¶skepumpe
FR2849788B1 (fr) Melangeur
FI20021817A (fi) Kanyyli
FI20031158A (fi) Inhalaattori
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
ATA12882003A (de) Osteosynthesevorrichtung
ATE374639T1 (de) Elektrotherapievorrichtung